Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis
Renzo Mora1, Angelo Salami, Francesco Mora
1ENT Department, University of Genoa, Largo R. Benzi 10, Genova 16100, Italy. renzomora@libero.it
Insights
Cefpodoxime proxetil effectively prevents recurrent pharyngotonsillitis in children. This second-generation cephalosporin treatment reduced symptoms and recurrences without adverse effects or resistance.
Area of Science:
- Pediatric infectious diseases
- Pharmacology and therapeutics
Background:
- Recurrent acute pharyngotonsillitis is common in children and young adults.
- Untreated pharyngotonsillitis can lead to severe complications.
- Cefpodoxime proxetil is a potent second-generation cephalosporin effective against Gram-positive and Gram-negative bacteria.
Purpose of the Study:
- To assess the efficacy of second-generation cephalosporins in preventing recurrent pharyngotonsillitis in pediatric patients.
- To evaluate cefpodoxime proxetil for prophylaxis of recurrent pharyngotonsillitis.
Main Methods:
- A randomized controlled trial involving 180 children aged 4-14 years.
- Participants had recurrent pharyngotonsillitis.
- Treatment groups received either cefpodoxime proxetil (100 mg twice daily for 6 days/month for 6 months) or a placebo.
Main Results:
- Cefpodoxime proxetil treatment demonstrated efficacy in reducing pharyngotonsillitis symptoms.
- The prophylaxis regimen helped prevent recurrent episodes of the illness.
- No significant side effects or bacterial resistance were observed during the study.
Conclusions:
- Cefpodoxime proxetil is a potentially effective prophylactic treatment for recurrent pharyngotonsillitis in children.
- The drug appears safe, with no observed side effects or development of bacterial resistance.
- Further research may support its use in managing pediatric pharyngotonsillitis.
Background:
Recurrent acute pharyngotonsillitis remains a common illness in children and young adults and can lead to serious complications if not treated. cefpodoxime proxetil is a second-generation oral cephalosporin, which shows potent antibacterial activity against both Gram-positive and Gram-negative bacteria and high stability in the presence of beta-lactamases.
Objective:
We aimed to evaluate the efficacy of second-generation cephalosporins in the prophylaxis of recurrent pharyngotonsillitis in children.
Methods:
A total of 180 children aged between 4 and 14 years with recurrent pharyngotonsillitis were randomized to receive either cefpodoxime proxetil (100 mg twice a day, 6 days a month for 6 months) or placebo (at the same dosage).
Results And Conclusions:
Our results show that treatment with cefpodoxime proxetil may be effective in reducing symptoms of recurrent pharyngotonsillitis and preventing recurrences without causing side effects or developing bacterial resistance.
Related Concept Videos
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:26Tonsillitis II: Management
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:27Streptococcal Pharyngitis